Roche To Teach Bangladesh’s Beximco To Make Invirase AIDS Drug (Bangladesh)
This article was originally published in PharmAsia News
Roche Holding says it plans to teach Bangladesh's Beximco Pharmaceuticals how to make one of its AIDS drugs to help stem the spread of HIV. The company plans to send teams to Beximco and to three companies in Africa to work at the local facilities and help them produce Invirase (saquinavir mesylate). Roche has agreements with nine companies in developing countries already and is considering applications from 26 others. (Click here for more
You may also be interested in...
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.
As one of the leading players in the US, albeit with a declining core business, Sandoz is naturally watching developments from the Federal Circuit’s precedential ruling on induced infringement for carved out indications. Management discussed the topic as Sandoz reported third-quarter financials.
With the India business on the road to recovery and the US growth outlook muted, Torrent hopes to keep the boat steady in fiscal 2021. It also expects an order in Q3 in a patent infringement case pertaining to AstraZeneca’s Farxiga, where it and multiple Indian firms are seeking to launch generic versions.